Filing Details

Accession Number:
0001593968-21-002537
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-13 15:47:22
Reporting Period:
2021-12-10
Accepted Time:
2021-12-13 15:47:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1673772 Rapt Therapeutics Inc. RAPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635616 G. Dirk Brockstedt C/O Rapt Therapeutics, Inc.,
561 Eccles Avenue
South San Francisco CA 94080
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-10 2,647 $6.30 22,459 No 4 M Direct
Common Stock Disposition 2021-12-10 2,647 $30.88 19,812 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2021-12-10 2,647 $0.00 2,647 $6.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
611 2029-03-27 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
  2. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.